Biocept Statistics
Biocept (BIOCQ) Stock Statistics & Valuation Metrics
Total Valuation
Biocept has a market cap or net worth of $525.00. The enterprise value is $6.21M.
- Market Cap
- $525.00
- Enterprise Value
- $6.21M
Share Statistics
Biocept has 2,626,026 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,626,026
- Owned by Insiders
- ―
- Owned by Institutions
- 5.21%
Financial Efficiency
Biocept’s return on equity (ROE) is -3.62 and return on invested capital (ROIC) is -117.56%.
- Return on Equity (ROE)
- -3.62
- Return on Assets (ROA)
- -1.04
- Return on Invested Capital (ROIC)
- -117.56%
- Return on Capital Employed (ROCE)
- -1.26
- Revenue Per Employee
- 517.16K
- Profits Per Employee
- -641.74K
- Employee Count
- 50
- Asset Turnover
- 0.84
- Inventory Turnover
- 37.57
Valuation Ratios
The current PE Ratio of Biocept is -0.00. Biocept’s PEG ratio is 0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Biocept had revenue of 25.86M and earned -32.09M in profits. Earnings per share was -56.78.
- Revenue
- 25.86M
- Gross Profit
- -2.58M
- Operating Income
- -31.98M
- Pretax Income
- -32.21M
- Net Income
- -32.09M
- EBITDA
- -30.24M
- Earnings Per Share (EPS)
- -56.78
Cash Flow
In the last 12 months, operating cash flow was -17.60M and capital expenditures -680,000, giving a free cash flow of -18.28M billion.
- Operating Cash Flow
- -17.60M
- Free Cash Flow
- -18.28M
- Free Cash Flow per Share
- -24.94
Dividends & Yields
Biocept pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2684952.38%
- Earnings Yield
- -28389193.93%
Stock Price Statistics
- Beta
- 97.85
- 52-Week Price Change
- -52.00%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Biocept upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Aug 12, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Biocept as a current ratio of 2.97, with Debt / Equity ratio of 136.67%
- Current Ratio
- 2.97
- Quick Ratio
- 2.83
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.03
- Interest Coverage Ratio
- -101.21
Taxes
In the past 12 months, Biocept has paid -125.00K in taxes.
- Income Tax
- -125.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Biocept EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.06.
- EV to Sales
- -0.03
- EV to EBITDA
- 0.03
- EV to Free Cash Flow
- 0.06
- EV to Operating Cash Flow
- 0.06
Balance Sheet
Biocept has $6.63M in cash and marketable securities with $11.59M in debt, giving a net cash position of -$4.96M billion.
- Cash & Marketable Securities
- $6.63M
- Total Debt
- $11.59M
- Net Cash
- -$4.96M
- Net Cash Per Share
- -$1.89
- Tangible Book Value Per Share
- $0.28
Margins
Gross margin is -9.99%, with operating margin of -123.69%, and net profit margin of -124.09%.
- Gross Margin
- -9.99%
- Operating Margin
- -123.69%
- Pretax Margin
- -124.57%
- Net Profit Margin
- -124.09%
- EBITDA Margin
- -116.95%
- EBIT Margin
- -123.35%

